Estrogen prevents airway hyperresponsiveness in a murine model of allergic asthma Source: Eur Respir J 2006; 28: Suppl. 50, 433s Year: 2006
Estrogen prevents airway inflammation and hyperresponsiveness in a murine model of acute allergic asthma Source: Eur Respir J 2007; 30: Suppl. 51, 360s Year: 2007
Dissociation of the effects of a steroid on inflammation compared to airway hyperresponsiveness (AHR) in a model of asthma in conscious mice Source: Eur Respir J 2001; 18: Suppl. 33, 30s Year: 2001
Effects of IL-4Rα blockade on lung inflammation and airway hyperresponsiveness using Mu317RAXMu, a murine surrogate for AMG 317, in a treatment model of cockroach allergen-induced asthma in mice Source: Annual Congress 2008 - Novel mechanisms in the pathogenesis of pulmonary inflammation Year: 2008
Inhaled PPAR-r agonist inhibit the airway inflammation in murine model of acute and chronic asthma Source: Eur Respir J 2007; 30: Suppl. 51, 24s Year: 2007
MMP-9 deficiency reduces airway inflammation and hyperresponsiveness in a mouse model of asthma Source: Eur Respir J 2001; 18: Suppl. 33, 20s Year: 2001
A dual role of IL-6 signalling and STAT-3 activation on airway inflammation versus airway hyperresponsiveness in a murine model of asthma Source: Eur Respir J 2002; 20: Suppl. 38, 568s Year: 2002
Obesity enhances allergen-induced airway inflammation in a murine model of asthma Source: International Congress 2019 – Modelling and monitoring of airway diseases Year: 2019
Activated protein C inhibits bronchial inflammation and hyperresponsiveness in a mouse model of asthma Source: Eur Respir J 2002; 20: Suppl. 38, 618s Year: 2002
Comparison of glucocorticoid and cysteinyl leukotriene receptor antagonist treatments in the airway remodeling induced by chronic airway inflammation in guinea pigs Source: Annual Congress 2008 - Novel experimental approaches to understanding asthma and COPD II Year: 2008
Involvement of NK1, 2 and 3 receptors on antigen-induced airway hyperresponsiveness and inflammation induced in guinea-pigs Source: Eur Respir J 2001; 18: Suppl. 33, 246s Year: 2001
The PAR2 -activating peptide SLIGRL inhibits airway hyper-responsiveness and eosinophilia in an acute murine model of allergic asthma Source: Annual Congress 2004 - Animal models of asthma and chronic bronchitis and their relevance in pulmonary pharmacology Year: 2004
The inflammation and the airway hyperresponsiveness in allergic asthma is inhibited by IL-10 dependent mechanism Source: Annual Congress 2007 - Mouse models of allergic airway inflammation Year: 2007
Hepatocyte growth factor attenuates airway hyperresponsiveness and airway inflammation in a murine model of asthma Source: Eur Respir J 2002; 20: Suppl. 38, 27s Year: 2002
Budesonide reverses IL-13–induced airway hyper-responsiveness but has little effect on β2 agonist response in human small airways Source: Annual Congress 2012 - The best of pharmacology treatment for asthma and COPD Year: 2012
B cells are crucial in the regulation of airway hyperreactivity in an experimental model of asthma Source: International Congress 2019 – Modelling and monitoring of airway diseases Year: 2019
Effect of 1,25(OH)2 D3 on the airway inflammation in asthmatic rat model Source: Eur Respir J 2005; 26: Suppl. 49, 580s Year: 2005
Disruption of CD44 variant 6 abolished bronchial hyperresponsiveness, inflammation and mast cell myositis in a murine model of asthma Source: Eur Respir J 2006; 28: Suppl. 50, 217s Year: 2006
Oral presentation: The role of mast cells, IL-13 and TRP channels in a mouse model of chemical-induced airway hyperresponsiveness Source: Lung Science Conference 2013 - Early origins and mechanisms of chronic lung disease Year: 2013
Oral presentation: The role of mast cells, IL-13 and TRP channels in a mouse model of chemical-induced airway hyperresponsiveness Source: Lung Science Conference 2013 - Early origins and mechanisms of chronic lung disease Year: 2013